The Charter of the French Language and its regulations govern the consultation of English-language content.


2601 Chemin de la Canardière
Québec (Québec)
G1J 2G3
Canada
Professor, Laval University
Department of Psychiatry and Neuroscience, Faculty of medicine
Researcher, Research Center of the Quebec Mental Health Institute
Director, Clinical and Cognitive Neuroscience division, CERVO Brain Research Center
Director of the Neuroscience Biostatistics Platform
Member of the Board
Axe de recherche:
Clinical and Cognitive Neuroscience
Professor Chantal Mérette is a specialist in the analysis of the complex data that is generated in neuroscience studies. Thanks to her expertise and that of her team of biostatisticians and epidemiologists (specialists in the factors influencing the health of populations), her research has made it possible to detect and validate biomarkers of risk of major neurodevelopmental diseases, including schizophrenia, recurrent major depression, and bipolar disorder.
Dr. Mérette’s research is highly collaborative. She is involved in the conceptualization of numerous research projects, in determining the required sample size, in estimating the power of a study, in developing predictive models, and in analyzing data after the results are collected. The common goal of these projects is to detect risk factors for a given disease, understand the cause-and-effect mechanism, and validate the effectiveness of a clinical trial intervention or comparative study of current treatments.
Dr. Mérette has developed the Neuroscience Biostatistics Platform whose goal is to provide neuroscience researchers with leading-edge methodologies to answer their research questions. The team of biostatisticians and epidemiologists she leads possesses all the skills needed to develop databases, identify the optimal quote for a study, propose the sampling method and the analysis that will maximize the chances of achieving the objectives of the study. Dr. Chantal Mérette is interested in several areas and psychiatric diseases and has contributed to studies on the genetics and treatments of insomnia, the development of cognitive structures or mental processes in young people at risk of schizophrenia or bipolar disorder, the effects of neglect or abuse on children on the development of psychoses, and genetic variants related to suicidal behavior, among others. It has resulted in several randomized clinical trials to validate the efficacy of new treatments or interventions, such as omega3 in menopausal patients, tele-rehabilitation in patients after knee surgery, or exercise in subjects burdened by a physical disability or a predisposition to develop a psychiatric illness.
Dr. Mérette and her team’s work in biostatistics in neuroscience is at the root of many advances in neuroscience, both in understanding the fundamental processes that underlie brain function, as well as in early detection and testing of clinical treatments for diseases and disorders of the brain.
Depuis 1994, Chantal Mérette a développé la Plateforme de Biostatistique en Neurosciences au Centre de recherche de l’Institut universitaire en santé mentale de Québec (IUSMQ). Elle supervise une équipe d’assistants de recherche qui détiennent des maîtrises en biostatistique et en épidémiologie.
La plateforme a pour mission d’offrir un support méthodologique et statistique de pointe à la recherche en neurosciences. De l’élaboration du protocole de recherche à la rédaction d’articles scientifiques, notre équipe possède les expertises requises pour concevoir votre devis d’étude, déterminer le plan d’échantillonnage, maximiser la puissance de l’étude, et analyser vos données de manière à exploiter leur plein potentiel et à en valoriser la portée des résultats.
Notre support s’étend à diverses approches méthodologiques incluant l’élaboration de bases de données, la conceptualisation d’essais cliniques, l’étude des facteurs confondants ou modifiants, la construction de modèles de prédiction ou les tests de non-infériorité.
Notre équipe a déjà largement contribué à l’avancement des connaissances en psychiatrie en plus d’avoir révélé des endophénotypes et biomarqueurs de risque pour ces maladies neurodéveloppementales.
C’est donc dans un esprit de collaboration et de poursuite d’excellence et de rigueur scientifique que notre plateforme de biostatistique vous invite à venir nous rencontrer.
Alexandra Painchaud; Marie-Josée Poulin; Célia Matte-Gagné; Chantal Mérette
Factors Associated With Severe Mental Illnesses Newly Diagnosed in Perinatal Psychiatric Care: Findings From a Large Clinical Cohort Journal Article
In: Ann Clin Psychiatry, vol. 37, no. 2, pp. 79–87, 2026, ISSN: 1547-3325.
@article{pmid41943799,
title = {Factors Associated With Severe Mental Illnesses Newly Diagnosed in Perinatal Psychiatric Care: Findings From a Large Clinical Cohort},
author = {Alexandra Painchaud and Marie-Josée Poulin and Célia Matte-Gagné and Chantal Mérette},
doi = {10.1177/10401237261434895},
issn = {1547-3325},
year = {2026},
date = {2026-05-01},
journal = {Ann Clin Psychiatry},
volume = {37},
number = {2},
pages = {79--87},
abstract = {BACKGROUND: The perinatal period represents a phase of increased psychiatric vulnerability, yet the factors linked to severe mental illnesses (SMIs) diagnosed during pregnancy or postpartum remain unclear. This study sought to identify associated and predictive factors of depression, bipolar disorder, and schizophrenia-related disorders diagnosed during pregnancy vs postpartum, with or without psychiatric comorbidity, in women seeking psychiatric care.nnMETHODS: Using a retrospective cohort design, data from 927 women who accessed specialized perinatal psychiatric services in Quebec City (Canada) were analyzed. Poisson regression models examined psychiatric, sociodemographic, medical, and obstetric correlates of perinatal SMIs.nnRESULTS: Distinct profiles emerged according to diagnosis timing, disorder type, and comorbidity. During pregnancy, associated factors included being single, absence of prior psychotropic use, musculoskeletal conditions, and cluster C personality disorders. Past postpartum psychosis predicted bipolar disorder diagnosed during pregnancy. In the postpartum period, key correlates included history of anxiety or (hypo)manic symptoms, somatic-related disorder, suicidal behavior, absence of previous psychiatric diagnosis, and no new diagnosis during pregnancy. Foreign nativity and lack of psychotropic treatment were linked to depression across both periods.nnCONCLUSIONS: Results highlight period-specific and shared factors underlying perinatal SMIs. Their identification may improve early detection and targeted interventions for maternal mental health.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Alexandra Painchaud; Marie-Josée Poulin; Célia Matte-Gagné; Chantal Mérette
In: Can J Psychiatry, vol. 70, no. 6, pp. 499–510, 2025, ISSN: 1497-0015.
@article{pmid40239126,
title = {The Complex Journey of Women in Perinatal Psychiatric Care: Susceptibility to Illness Onset, Comorbidity and Clinical Trajectories: Le parcours complexe des femmes en psychiatrie périnatale : vulnérabilité, comorbidités et trajectoires cliniques},
author = {Alexandra Painchaud and Marie-Josée Poulin and Célia Matte-Gagné and Chantal Mérette},
doi = {10.1177/07067437251328347},
issn = {1497-0015},
year = {2025},
date = {2025-06-01},
journal = {Can J Psychiatry},
volume = {70},
number = {6},
pages = {499--510},
abstract = {BackgroundMore than one in five women deal with a psychiatric disorder during the perinatal period. Whereas perinatal depression is well documented, there is still little research on the full range of perinatal psychiatric disorders and their clinical evolution across this whole period. The present study investigated the susceptibility to psychiatric illness during pregnancy and up to one year postpartum. We aimed to identify the most frequent disorders and comorbidities arising in each perinatal period. We outlined the clinical trajectories of these disorders in terms of evolution across past history, pregnancy and postpartum.MethodThrough a retrospective longitudinal design, data were collected in 2019-2020 from the medical records of the cohort of 964 women who required care in a tertiary perinatal psychiatry clinic located in Quebec City (Canada) between 2004 and 2020. Incidence rates of the full range of psychiatric disorders were estimated per period and their evolution across time identified clinical trajectories.ResultsDuring pregnancy, 34 different disorders were newly diagnosed with incidence rates ranging from 0.1% to 15.5% (45.6% of women having had at least one disorder diagnosed during pregnancy) whereas, during postpartum, 36 disorders were newly diagnosed with incidence rates ranging from 0.1% to 31.0% (67.5% of women having had at least one disorder diagnosed during postpartum). For most disorders, rates were significantly higher in postpartum than in pregnancy. A woman could develop multiple disorders during a given perinatal period: this comorbidity involved various combinations of diagnoses in 28% of women during pregnancy and 38% during postpartum. We outlined 52 different clinical trajectories from past history to postpartum, underlining the heterogeneity of the perinatal course.ConclusionsPregnancy is a susceptible period for women with past psychiatric histories whereas postpartum could trigger a new illness in women without a past history or pregnancy-onset psychiatric disorder.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Lina Peñuela; Gillian King; Annie Labbé; Toni Lui; Désirée B Maltais; Chantal Mérette; Helene Moffet; Amy C McPherson
In: Dev Neurorehabil, vol. 28, no. 6-7, pp. 238–251, 2025, ISSN: 1751-8431.
@article{pmid40958588,
title = {Children and Teens in Charge of Their Health (CATCH): A Feasibility Randomized Controlled Trial of Solution-Focused Coaching to Foster Healthy Lifestyles in Children with Spina Bifida or Cerebral Palsy},
author = {Lina Peñuela and Gillian King and Annie Labbé and Toni Lui and Désirée B Maltais and Chantal Mérette and Helene Moffet and Amy C McPherson},
doi = {10.1080/17518423.2025.2541830},
issn = {1751-8431},
year = {2025},
date = {2025-01-01},
journal = {Dev Neurorehabil},
volume = {28},
number = {6-7},
pages = {238--251},
abstract = {This feasibility randomized controlled trial (RCT) evaluated "Children and Teens in Charge of Their Health" (CATCH), a solution-focused coaching intervention promoting physical activity and healthy eating in children with spina bifida or cerebral palsy. All participants received standard care and printed materials; the intervention group also received up to eight coaching sessions over six months. Quantitative analyses examined whether feasibility criteria were met and the responsiveness of measures assessing goal attainment, functional mobility, dietary intake and physical activity at four timepoints over 12 months. Nineteen participants were randomized. While stratification and fidelity criteria were met, recruitment and retention were not, likely impacted by Covid-19. CATCH participants showed significant improvements in two of three goal attainment scores, along with positive trends in functional mobility, active hours, and some dietary measures compared to controls. Most outcome measures were responsive, although protocol adaptations are needed for a full-scale RCT.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Annie Vallières; Alric Pappathomas; Séverine de Billy Garnier; Chantal Mérette; Julie Carrier; Tyna Paquette; Célyne H Bastien
Behavioural therapy for shift work disorder improves shift workers’ sleep, sleepiness and mental health: A pilot randomised control trial Journal Article
In: J Sleep Res, vol. 33, no. 6, pp. e14162, 2024, ISSN: 1365-2869.
@article{pmid38443322,
title = {Behavioural therapy for shift work disorder improves shift workers' sleep, sleepiness and mental health: A pilot randomised control trial},
author = {Annie Vallières and Alric Pappathomas and Séverine de Billy Garnier and Chantal Mérette and Julie Carrier and Tyna Paquette and Célyne H Bastien},
doi = {10.1111/jsr.14162},
issn = {1365-2869},
year = {2024},
date = {2024-12-01},
journal = {J Sleep Res},
volume = {33},
number = {6},
pages = {e14162},
abstract = {The present study evaluates the efficacy of behavioural therapy adapted for shift work disorder with a randomised control design in a healthcare population. Forty-three night shift workers (m. age: 34 years; 77% women) experiencing shift work disorder were randomised to either the behavioural therapy for shift work disorder (BT-SWD) or a waiting-list control group offered after the waiting period. Participants completed questionnaires on insomnia, sleepiness and mental health pre- and post-treatment, pre- and post-waiting, and at follow-up, and a sleep diary. As night shift workers alternate between sleeping during the day after their night shifts and transitioning to nighttime sleep on days off, insomnia severity and sleep variables were analysed for daytime and nighttime sleep. The BT-SWD involved sleep restriction therapy, stimulus control and fixed sleep periods in the dark. Statistical analyses were performed under intent-to-treat and per-protocol approaches. Repeated-measures two-way ANCOVA analysis, controlling for age, sex and pre-treatment daytime total sleep time, was performed with Bonferroni corrections, and between-group effect sizes computed. Fourteen participants dropped out after randomisation. Under the intent-to-treat analysis, BT-SWD participants had a significant greater decrease in daytime insomnia severity and an increase in daytime total sleep time at post-treatment than the control group, with large between-group effect sizes (-1.25 and 0.89). These corresponding results were also significant with large effect sizes under the per-protocol analysis. Sleepiness, anxiety and depression levels improved at post-treatment and maintained at follow-up when the BT-SWD treated controls were added to the BT-SWD group. The behavioural therapy for shift work disorder can be used to improve the sleep and mental health of healthcare night workers.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Audette Sylvestre; Mélissa Di Sante; Catherine Julien; Caroline Bouchard; Chantal Mérette
Developmental trajectories of speech and language in neglected children aged 3 to 5 years: Results of the ELLAN study Journal Article
In: Child Abuse Negl, vol. 146, pp. 106448, 2023, ISSN: 1873-7757.
@article{pmid37722293,
title = {Developmental trajectories of speech and language in neglected children aged 3 to 5 years: Results of the ELLAN study},
author = {Audette Sylvestre and Mélissa Di Sante and Catherine Julien and Caroline Bouchard and Chantal Mérette},
doi = {10.1016/j.chiabu.2023.106448},
issn = {1873-7757},
year = {2023},
date = {2023-12-01},
journal = {Child Abuse Negl},
volume = {146},
pages = {106448},
abstract = {BACKGROUND: Neglected children are at high risk for significant difficulties in speech and language development. Because no longitudinal study has been conducted to date, the dynamic description of development during the preschool period is unknown.nnOBJECTIVES: Establish the developmental trajectories of speech sounds, receptive and expressive vocabulary, and morphosyntax among neglected children during the preschool years and compare them with those of non-neglected children.nnPARTICIPANTS AND SETTING: Participants are 69 neglected children and 99 same age non-neglected peers (37 and 46 males respectively) recruited at 36 months of age. Data were collected at home.nnMETHODS: Data were collected at six-month intervals between the ages of 3 and 5.5 years using psychometrically robust tools. Neglected and control groups were compared according to age using repeated measures ANOVAs on all variables. A discrete mixture model for clustering longitudinal data was used for testing the heterogeneity of the language trajectories among neglected children.nnRESULTS: The language development of the neglected children as a whole group is lower than that of the control group for all variables. Two subgroups are identified within the neglected group: one with a developmental trajectory similar to that of the non-neglected children, and another whose trajectory is far below that of the control group. The effect sizes of these differences vary between 1.4 and 3 standard deviations under the mean.nnCONCLUSIONS: A large proportion of neglected children present significant speech and language difficulties from the age of 3, but some of them catch up and develop similarly to non-neglected children.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Marc-André Dubois; Charles-Antoine Pelletier; Chantal Mérette; Valérie Jomphe; Rose Turgeon; Richard E Bélanger; Simon Grondin; Marc Hébert
Evaluation of electroretinography (ERG) parameters as a biomarker for ADHD Journal Article
In: Prog Neuropsychopharmacol Biol Psychiatry, vol. 127, pp. 110807, 2023, ISSN: 1878-4216.
@article{pmid37290571,
title = {Evaluation of electroretinography (ERG) parameters as a biomarker for ADHD},
author = {Marc-André Dubois and Charles-Antoine Pelletier and Chantal Mérette and Valérie Jomphe and Rose Turgeon and Richard E Bélanger and Simon Grondin and Marc Hébert},
doi = {10.1016/j.pnpbp.2023.110807},
issn = {1878-4216},
year = {2023},
date = {2023-12-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {127},
pages = {110807},
abstract = {BACKGROUND: The retina is recognized as an accessible part of the brain due to their common embryonic origin. The electroretinogram (ERG) has proven to be a valuable tool for detecting schizophrenia and bipolarity. We therefore investigated its ability to detect ADHD.nnMETHODS: The cone and rod luminance response functions of the ERG were recorded in 26 ADHD subjects (17 women and 9 men) and 25 controls (16 women and 9 men).nnRESULTS: No significant differences were found between the mixed groups, but sexual dysmorphia was observed in the significant results. In males, a significant prolonged cone a-wave latency was observed in the ADHD group. In females, we observed a significant decrease in the cone a- and b-wave amplitudes and a trend for a prolonged cone b-wave latency as well as a higher scotopic mixed rod-cone a-wave in the ADHD group.nnCONCLUSION: The data obtained in this study show the potential of the ERG to detect ADHD, warranting further large-scale studies.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Simon Lafrenière; Fatemeh Gholi-Zadeh-Kharrat; Caroline Sirois; Victoria Massamba; Louis Rochette; Camille Brousseau-Paradis; Simon Patry; Christian Gagné; Morgane Lemasson; Geneviève Gariépy; Chantal Mérette; Elham Rahme; Alain Lesage
In: Soc Psychiatry Psychiatr Epidemiol, vol. 58, no. 4, pp. 629–639, 2023, ISSN: 1433-9285.
@article{pmid36163429,
title = {The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study},
author = {Simon Lafrenière and Fatemeh Gholi-Zadeh-Kharrat and Caroline Sirois and Victoria Massamba and Louis Rochette and Camille Brousseau-Paradis and Simon Patry and Christian Gagné and Morgane Lemasson and Geneviève Gariépy and Chantal Mérette and Elham Rahme and Alain Lesage},
doi = {10.1007/s00127-022-02369-w},
issn = {1433-9285},
year = {2023},
date = {2023-04-01},
journal = {Soc Psychiatry Psychiatr Epidemiol},
volume = {58},
number = {4},
pages = {629--639},
abstract = {PURPOSE: Electroconvulsive therapy (ECT) is effective for treating several psychiatric disorders. However, only a minority of patients are treated with ECT. It is of primary importance to characterize their profile for epidemiological purposes and to inform clinical practice. We aimed to characterize the longitudinal profile of psychopathology and services utilization of patients first treated with ECT.nnMETHODS: We conducted a population-based comparative study using data from a national administrative database in Quebec. Patients who received a first ECT between 2002 and 2016 were compared to controls who were hospitalized in psychiatry but did not receive ECT. We performed descriptive analyses to compare psychiatric diagnoses, domains of psychopathology (internalizing, externalizing and thought/psychotic disorders), medical services and medication use in the 5 years prior to the ECT or hospitalization.nnRESULTS: 5 080 ECT patients were compared with 179 594 controls. Depressive, anxiety, bipolar and psychotic disorders were more frequent in the ECT group. 96.2% of ECT patients had been diagnosed with depression and 53.8% with a primary psychotic disorder. In the ECT group, 1.0% had been diagnosed exclusively with depression and 47.0% had disorders from that belong to all three domains of psychopathology. Having both internalizing and thought/psychotic disorders was associated with an increased likelihood of receiving ECT vs having internalizing disorders alone (unadjusted OR = 2.93; 95% CI = 2.63, 3.26). All indicators of mental health services utilization showed higher use among ECT patients.nnCONCLUSION: Our results provide robust evidence of complex longitudinal psychopathology and extensive services utilization among ECT patients.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Rossana Peredo; Marc Hébert; Chantal Mérette
Developing a clinical decision tool based on electroretinogram to monitor the risk of severe mental illness Journal Article
In: BMC Psychiatry, vol. 22, no. 1, pp. 718, 2022, ISSN: 1471-244X.
@article{pmid36401192,
title = {Developing a clinical decision tool based on electroretinogram to monitor the risk of severe mental illness},
author = {Rossana Peredo and Marc Hébert and Chantal Mérette},
doi = {10.1186/s12888-022-04375-3},
issn = {1471-244X},
year = {2022},
date = {2022-11-01},
journal = {BMC Psychiatry},
volume = {22},
number = {1},
pages = {718},
abstract = {BACKGROUND: We have shown that electroretinograms can discriminate between patients with severe mental illness (SMI) and healthy controls in previous studies. We now intend to enhance the development and clinical utility of ERG as a biological tool to monitor the risk of SMI.nnMETHODOLOGY: A sample of 301 SMI patients (bipolar disorder or schizophrenia) and 200 controls was first split into a training (N = 401) and testing dataset (N = 100). A logistic regression using ERG was modeled in the training data, while external validation and discriminative ability were assessed in the testing data. A decision curve analysis was used to test clinical usefulness. Moreover, the identification of thresholds of uncertainty based on the two-graph ROC and the interval of uncertainty was used to enhance prediction.nnRESULTS: The discriminative assessment of the ERG showed very high sensitivity (91%) and specificity (89%) after considering uncertainty levels. Furthermore, for prediction probabilities ranging from 0.14 to 0.95 in the testing data, the net benefit of using our ERG model to decide whether to intervene or not exceeded that of never or always intervening.nnCONCLUSION: The ERG predicted SMI risk with a high level of accuracy when uncertainty was accounted for. This study further supports the potential of ERG to become a useful clinical decision tool to decide the course of action for subjects at risk of SMI. However, further investigation is still needed in longitudinal studies to assess the external validity of the instrument.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Annie LeBlanc; Marie Baron; Patrick Blouin; George Tarabulsy; Francois Routhier; Catherine Mercier; Jean-Pierre Despres; Marc Hébert; Yves De Koninck; Caroline Cellard; Delphine Collin-Vézina; Nancy Côté; Émilie Dionne; Richard Fleet; Marie-Hélène Gagné; Maripier Isabelle; Lily Lessard; Matthew Menear; Chantal Merette; Marie-Christine Ouellet; Marc-André Roy; Marie-Christine Saint-Jacques; Claudia Savard;
In: BMJ Open, vol. 12, no. 4, pp. e048749, 2022, ISSN: 2044-6055.
@article{pmid35379610,
title = {For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol},
author = {Annie LeBlanc and Marie Baron and Patrick Blouin and George Tarabulsy and Francois Routhier and Catherine Mercier and Jean-Pierre Despres and Marc Hébert and Yves De Koninck and Caroline Cellard and Delphine Collin-Vézina and Nancy Côté and Émilie Dionne and Richard Fleet and Marie-Hélène Gagné and Maripier Isabelle and Lily Lessard and Matthew Menear and Chantal Merette and Marie-Christine Ouellet and Marc-André Roy and Marie-Christine Saint-Jacques and Claudia Savard and },
doi = {10.1136/bmjopen-2021-048749},
issn = {2044-6055},
year = {2022},
date = {2022-04-01},
journal = {BMJ Open},
volume = {12},
number = {4},
pages = {e048749},
abstract = {INTRODUCTION: The COVID-19 pandemic and associated restrictive measures have caused important disruptions in economies and labour markets, changed the way we work and socialise, forced schools to close and healthcare and social services to reorganise. This unprecedented crisis forces individuals to make considerable efforts to adapt and will have psychological and social consequences, mainly on vulnerable individuals, that will remain once the pandemic is contained and will most likely exacerbate existing social and gender health inequalities. This crisis also puts a toll on the capacity of our healthcare and social services structures to provide timely and adequate care. The MAVIPAN (Ma vie et la pandémie/ My Life and the Pandemic) study aims to document how individuals, families, healthcare workers and health organisations are affected by the pandemic and how they adapt.nnMETHODS AND ANALYSIS: MAVIPAN is a 5-year longitudinal prospective cohort study launched in April 2020 across the province of Quebec (Canada). Quantitative data will be collected through online questionnaires (4-6 times/year) according to the evolution of the pandemic. Qualitative data will be collected with individual and group interviews and will seek to deepen our understanding of coping strategies. Analysis will be conducted under a mixed-method umbrella, with both sequential and simultaneous analyses of quantitative and qualitative data.nnETHICS AND DISSEMINATION: MAVIPAN aims to support the healthcare and social services system response by providing high-quality, real-time information needed to identify those who are most affected by the pandemic and by guiding public health authorities' decision making regarding intervention and resource allocation to mitigate these impacts. MAVIPAN was approved by the Ethics Committees of the Primary Care and Population Health Research Sector of CIUSSS de la Capitale-Nationale (Committee of record) and of the additional participating institutions.nnTRIAL REGISTRATION NUMBER: NCT04575571.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Isabel Moreau; Marc Hébert; Michel Maziade; Alexandra Painchaud; Chantal Mérette
The Electroretinogram as a Potential Biomarker of Psychosis in Children at Familial Risk Journal Article
In: Schizophr Bull Open, vol. 3, no. 1, pp. sgac016, 2022, ISSN: 2632-7899.
@article{pmid39144760,
title = {The Electroretinogram as a Potential Biomarker of Psychosis in Children at Familial Risk},
author = {Isabel Moreau and Marc Hébert and Michel Maziade and Alexandra Painchaud and Chantal Mérette},
doi = {10.1093/schizbullopen/sgac016},
issn = {2632-7899},
year = {2022},
date = {2022-01-01},
journal = {Schizophr Bull Open},
volume = {3},
number = {1},
pages = {sgac016},
abstract = {We previously proposed the electroretinogram (ERG) as a promising biomarker of major psychiatric disorders such as schizophrenia (SZ) and bipolar disorder (BP), given that we found anomalies in the ERG parameters of patients with these diagnoses as well as in their children who are at high risk (HR) of developing such disorders. The aim of the present study is to investigate the usefulness of the ERG for individual detection, among HR children, of an ERG profile resembling that of a SZ patient, as this may indicate a stronger likelihood of transition to psychosis. Using a logistic regression model previously derived from the ERG assessments of SZ patients and control (CT) subjects, individual risk scores were obtained for 61 HR and 80 CT youth. Those with a very high individual risk score were classified as "schizophrenia-like" (). We found that the HR subjects were 3.5 times more likely to be classified as than the CT subjects (95% CI [1.1-11.8]). Furthermore, among the HR subjects, we studied the relationship between the classification and psychotic-like experiences and found that HR subjects classified as were 2.7 times more likely than all remaining HR subjects to have experienced psychotic-like symptoms (95% CI [1.3-4.6]), and 6.8 times more likely than those with a very low individual risk score (95% CI [1.4-40.4]). Our results suggest that a model previously derived from ERG data on SZ patients could be a potential tool for early detection of the susceptibility to a psychotic-like disorder among familial HR children.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}

